Byterna Therapeutics
Contact Us

MANAGEMENT TEAM

Science-led company building.

Byterna’s leadership connects scientific strategy, product development and company building across its Shanghai and Singapore operations.

Andy Xian Zeng

CO-FOUNDER & CHIEF EXECUTIVE OFFICER

Andy Xian Zeng, Ph.D.

Andy Xian Zeng leads Byterna’s strategy across circular mRNA, in vivo immune-cell programming, personalized cancer vaccines and integrated technology development.